108 related articles for article (PubMed ID: 1988130)
1. Solutol HS 15, nontoxic polyoxyethylene esters of 12-hydroxystearic acid, reverses multidrug resistance.
Coon JS; Knudson W; Clodfelter K; Lu B; Weinstein RS
Cancer Res; 1991 Feb; 51(3):897-902. PubMed ID: 1988130
[TBL] [Abstract][Full Text] [Related]
2. In vitro investigation on the impact of Solutol HS 15 on the uptake of colchicine into rat hepatocytes.
Bravo González RC; Boess F; Durr E; Schaub N; Bittner B
Int J Pharm; 2004 Jul; 279(1-2):27-31. PubMed ID: 15234791
[TBL] [Abstract][Full Text] [Related]
3. Comparison of solutol HS 15, Cremophor EL and novel ethoxylated fatty acid surfactants as multidrug resistance modification agents.
Buckingham LE; Balasubramanian M; Emanuele RM; Clodfelter KE; Coon JS
Int J Cancer; 1995 Aug; 62(4):436-42. PubMed ID: 7635569
[TBL] [Abstract][Full Text] [Related]
4. Impact of Solutol HS 15 on the pharmacokinetic behaviour of colchicine upon intravenous administration to male Wistar rats.
Bittner B; González RC; Walter I; Kapps M; Huwyler J
Biopharm Drug Dispos; 2003 May; 24(4):173-81. PubMed ID: 12698501
[TBL] [Abstract][Full Text] [Related]
5. Effects of vinblastine, colchicine, and verapamil on rhodamine 123 accumulation in human P-glycoprotein-positive leukemia cells.
Lautier D; Canitrot Y; Salmon JM
Anticancer Res; 1994; 14(6B):2589-95. PubMed ID: 7872686
[TBL] [Abstract][Full Text] [Related]
6. Two pyridine analogues with more effective ability to reverse multidrug resistance and with lower calcium channel blocking activity than their dihydropyridine counterparts.
Shudo N; Mizoguchi T; Kiyosue T; Arita M; Yoshimura A; Seto K; Sakoda R; Akiyama S
Cancer Res; 1990 May; 50(10):3055-61. PubMed ID: 1970752
[TBL] [Abstract][Full Text] [Related]
7. Reversal of multidrug resistance phenotype by surfactants: relationship to membrane lipid fluidity.
Dudeja PK; Anderson KM; Harris JS; Buckingham L; Coon JS
Arch Biochem Biophys; 1995 May; 319(1):309-15. PubMed ID: 7771801
[TBL] [Abstract][Full Text] [Related]
8. Single cell analysis of daunomycin uptake and efflux in multidrug-resistant and -sensitive KB cells: effects of verapamil and other drugs.
Willingham MC; Cornwell MM; Cardarelli CO; Gottesman MM; Pastan I
Cancer Res; 1986 Nov; 46(11):5941-6. PubMed ID: 3756931
[TBL] [Abstract][Full Text] [Related]
9. Pervilleine A, a novel tropane alkaloid that reverses the multidrug-resistance phenotype.
Mi Q; Cui B; Silva GL; Lantvit D; Lim E; Chai H; You M; Hollingshead MG; Mayo JG; Kinghorn AD; Pezzuto JM
Cancer Res; 2001 May; 61(10):4030-7. PubMed ID: 11358822
[TBL] [Abstract][Full Text] [Related]
10. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW
J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852
[TBL] [Abstract][Full Text] [Related]
11. Selective modulation of P-glycoprotein-mediated drug resistance.
Bebawy M; Morris MB; Roufogalis BD
Br J Cancer; 2001 Dec; 85(12):1998-2003. PubMed ID: 11747345
[TBL] [Abstract][Full Text] [Related]
12. Reversal of Vinca alkaloid resistance but not multiple drug resistance in human leukemic cells by verapamil.
Beck WT; Cirtain MC; Look AT; Ashmun RA
Cancer Res; 1986 Feb; 46(2):778-84. PubMed ID: 3455678
[TBL] [Abstract][Full Text] [Related]
13. Reduced drug resistance in a multidrug resistant cell line by 5,8,11,14-eicosatetraynoic acid.
Anderson KM; Harris JE
Res Commun Mol Pathol Pharmacol; 1994 Nov; 86(2):195-203. PubMed ID: 7881868
[TBL] [Abstract][Full Text] [Related]
14. Pervilleine F, a new tropane alkaloid aromatic ester that reverses multidrug resistance.
Mi Q; Cui B; Lantvit D; Reyes-Lim E; Chai H; Pezzuto JM; Kinghorn AD; Swanson SM
Anticancer Res; 2003; 23(5A):3607-15. PubMed ID: 14666656
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of P-glycoprotein inhibitors on NIH3T3 cells transfected with wild-type (G185) or mutant (V185) multidrug transporters.
Cardarelli CO; Aksentijevich I; Pastan I; Gottesman MM
Cancer Res; 1995 Mar; 55(5):1086-91. PubMed ID: 7866993
[TBL] [Abstract][Full Text] [Related]
16. Characterization of 2-chloro-N10-substituted phenoxazines for reversing multidrug resistance in cancer cells.
Thimmaiah KN; Jayashree BS; Germain GS; Houghton PJ; Horton JK
Oncol Res; 1998; 10(1):29-41. PubMed ID: 9613455
[TBL] [Abstract][Full Text] [Related]
17. Modulation of drug sensitivity by dipyridamole in multidrug resistant tumor cells in vitro.
Shalinsky DR; Andreeff M; Howell SB
Cancer Res; 1990 Dec; 50(23):7537-43. PubMed ID: 1979245
[TBL] [Abstract][Full Text] [Related]
18. Characterization of multidrug-resistant pituitary tumor cells.
Nelson EJ; Hinkle PM
Endocrinology; 1992 Jun; 130(6):3246-56. PubMed ID: 1350759
[TBL] [Abstract][Full Text] [Related]
19. In vitro investigation on the impact of the surface-active excipients Cremophor EL, Tween 80 and Solutol HS 15 on the metabolism of midazolam.
Bravo González RC; Huwyler J; Boess F; Walter I; Bittner B
Biopharm Drug Dispos; 2004 Jan; 25(1):37-49. PubMed ID: 14716751
[TBL] [Abstract][Full Text] [Related]
20. Characterization of tropane alkaloid aromatic esters that reverse the multidrug-resistance phenotype.
Mi Q; Cui B; Chávez D; Chai H; Zhu H; Cordell GA; Hedayat S; Kinghorn AD; Pezzuto JM
Anticancer Res; 2002; 22(3):1385-97. PubMed ID: 12168815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
